• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在不同年龄段中,较长的眼轴长度对威胁视力的糖尿病视网膜病变有保护作用吗?一项针对736名患者的多中心队列研究。

Is longer axial length protective of vision-threatening diabetic retinopathy across different ages? A multicenter cohort of 736 patients.

作者信息

Xu Mingpeng, Li Bo, Li Chenxin, Chai Peiwei, Qiu Qinghua, Zheng Zhi, Chen Qian, Luo Dawei, Xu Xiaofang, Zhou Chuandi

机构信息

Department of Ophthalmology, Xinhua Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.

Department of Ophthalmology, The Fourth Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China.

出版信息

Int J Retina Vitreous. 2024 Oct 10;10(1):74. doi: 10.1186/s40942-024-00593-x.

DOI:10.1186/s40942-024-00593-x
PMID:39390534
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11465653/
Abstract

PURPOSE

Vision-threatening diabetic retinopathy (VTDR) included severe non-proliferative diabetic retinopathy (NPDR), proliferative diabetic retinopathy (PDR) and clinically significant diabetic macular edema (DME). To compare the axial length (AL) and assess its influence on VTDR across different ages.

METHODS

A retrospective cohort study. Medical chart review was performed in 736 consecutive patients with VTDR. The patients were divided into young (≤ 45 years) and elderly group (> 45 years) based on their age at the diagnosis of VTDR. After at least one year of standardized treatments, all eligible patients were followed up. The main outcome measures included the presence of tractional retinal detachment (TRD) involving foveal, final best-corrected visual acuity (BCVA), the development of neovascular glaucoma (NVG), and recurrent vitreous hemorrhage (VH) post-vitrectomy. ALs were compared between two age groups. The impact of AL on clinical outcomes was determined by logistic analyses after controlling for systemic parameters.

RESULTS

The study included 144 patients ≤ 45 years and 592 patients > 45 years. Young patients had significantly longer AL than elderly participants (23.9 mm vs 23.0 mm, p < 0.001). Over a median follow-up of 25.9 months, a larger proportion of young patients developed TRD (34.7% vs 16.2%, p < 0.001) and recurrent VH (18.6% vs 10.3%, p = 0.040) than elderly patients. In elderly group, longer AL is an independent protective factor in preventing TRD (odds ratio [OR], 0.5; 95% confidence interval [CI], 0.4-0.7; P < 0.001). However, this beneficial effect was not observed in young patients.

CONCLUSIONS

Young patients with VTDR exhibited significantly longer AL but more aggressive clinical signs with compromised prognosis. In elderly group, a longer AL independently reduced the risk of TRD, while this protective effect did not exist for young patients.

摘要

目的

威胁视力的糖尿病视网膜病变(VTDR)包括严重非增殖性糖尿病视网膜病变(NPDR)、增殖性糖尿病视网膜病变(PDR)和具有临床意义的糖尿病黄斑水肿(DME)。比较不同年龄组的眼轴长度(AL),并评估其对VTDR的影响。

方法

一项回顾性队列研究。对736例连续的VTDR患者进行病历审查。根据VTDR诊断时的年龄将患者分为年轻组(≤45岁)和老年组(>45岁)。在至少一年的标准化治疗后,对所有符合条件的患者进行随访。主要观察指标包括累及黄斑的牵拉性视网膜脱离(TRD)的存在情况、最终最佳矫正视力(BCVA)、新生血管性青光眼(NVG)的发生情况以及玻璃体切除术后复发性玻璃体出血(VH)情况。比较两个年龄组的AL。在控制全身参数后,通过逻辑分析确定AL对临床结局的影响。

结果

该研究纳入了144例年龄≤45岁的患者和592例年龄>45岁的患者。年轻患者的AL显著长于老年参与者(23.9mm对23.0mm,p<0.001)。在中位随访25.9个月期间,年轻患者发生TRD(34.7%对16.2%,p<0.001)和复发性VH(18.6%对10.3%,p=0.040)的比例高于老年患者。在老年组中,较长的AL是预防TRD的独立保护因素(比值比[OR],0.5;95%置信区间[CI],0.4 - 0.7;P<0.001)。然而,在年轻患者中未观察到这种有益效果。

结论

VTDR年轻患者的AL显著更长,但临床体征更具侵袭性,预后较差。在老年组中,较长的AL独立降低了TRD的风险,而年轻患者不存在这种保护作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8253/11465653/74a54b192d4c/40942_2024_593_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8253/11465653/74a54b192d4c/40942_2024_593_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8253/11465653/74a54b192d4c/40942_2024_593_Fig1_HTML.jpg

相似文献

1
Is longer axial length protective of vision-threatening diabetic retinopathy across different ages? A multicenter cohort of 736 patients.在不同年龄段中,较长的眼轴长度对威胁视力的糖尿病视网膜病变有保护作用吗?一项针对736名患者的多中心队列研究。
Int J Retina Vitreous. 2024 Oct 10;10(1):74. doi: 10.1186/s40942-024-00593-x.
2
Statin use and the risk of progression to vision threatening diabetic retinopathy.他汀类药物的使用与威胁视力的糖尿病性视网膜病变进展的风险。
Pharmacoepidemiol Drug Saf. 2022 Jun;31(6):652-660. doi: 10.1002/pds.5426. Epub 2022 Mar 15.
3
Clinical Characteristics and Surgical Outcomes of Patients Undergoing Pars Plana Vitrectomy for Proliferative Diabetic Retinopathy.增生型糖尿病视网膜病变行玻璃体切除术患者的临床特征和手术结果。
Ophthalmol Retina. 2024 Aug;8(8):823-831. doi: 10.1016/j.oret.2024.02.015. Epub 2024 Mar 4.
4
Association of Fenofibrate Use and the Risk of Progression to Vision-Threatening Diabetic Retinopathy.非诺贝特使用与威胁视力的糖尿病视网膜病变进展风险的关联。
JAMA Ophthalmol. 2022 May 1;140(5):529-532. doi: 10.1001/jamaophthalmol.2022.0633.
5
Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy.增生性糖尿病性视网膜病变在糖尿病性视网膜病变患者中发展和进展的预测因素。
Cochrane Database Syst Rev. 2023 Feb 22;2(2):CD013775. doi: 10.1002/14651858.CD013775.pub2.
6
Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy.抗血管内皮生长因子联合玻璃体切除术治疗增生性糖尿病视网膜病变并发症。
Cochrane Database Syst Rev. 2023 May 31;5(5):CD008214. doi: 10.1002/14651858.CD008214.pub4.
7
Risk Factors of Neovascular Glaucoma After 25-gauge Vitrectomy for Proliferative Diabetic Retinopathy with Vitreous Hemorrhage: A Retrospective Multicenter Study.增生型糖尿病视网膜病变伴玻璃体积血 25G 玻璃体切割术后新生血管性青光眼的危险因素:一项回顾性多中心研究。
Sci Rep. 2019 Oct 16;9(1):14858. doi: 10.1038/s41598-019-51411-6.
8
Anti-vascular endothelial growth factor for prevention of postoperative vitreous cavity haemorrhage after vitrectomy for proliferative diabetic retinopathy.抗血管内皮生长因子预防增殖性糖尿病视网膜病变玻璃体切除术后玻璃体腔出血
Cochrane Database Syst Rev. 2015 Aug 7;2015(8):CD008214. doi: 10.1002/14651858.CD008214.pub3.
9
Characteristics and outcomes of vitrectomy for proliferative diabetic retinopathy in young versus senior patients.年轻患者与老年患者行玻璃体切除术治疗增生型糖尿病视网膜病变的特征和结局。
BMC Ophthalmol. 2020 Oct 19;20(1):416. doi: 10.1186/s12886-020-01688-3.
10
Anaemia and the risk of progression from non-proliferative diabetic retinopathy to vision threatening diabetic retinopathy.贫血与非增殖性糖尿病性视网膜病变进展为威胁视力的糖尿病性视网膜病变的风险。
Eye (Lond). 2020 May;34(5):934-941. doi: 10.1038/s41433-019-0617-6. Epub 2019 Oct 4.

本文引用的文献

1
Prevalence, Progression, and Modifiable Risk Factors for Diabetic Retinopathy in Youth and Young Adults With Youth-Onset Type 1 and Type 2 Diabetes: The SEARCH for Diabetes in Youth Study.青少年和青年 1 型和 2 型糖尿病患者中糖尿病视网膜病变的患病率、进展及其可改变的危险因素:青少年糖尿病研究(SEARCH)。
Diabetes Care. 2023 Jun 1;46(6):1252-1260. doi: 10.2337/dc22-2503.
2
Clinical features and surgical outcomes of complications of proliferative diabetic retinopathy in young adults with type 1 diabetes mellitus versus type 2 diabetes mellitus - A comparative observational study.1 型糖尿病与 2 型糖尿病青年患者增生性糖尿病视网膜病变并发症的临床特征和手术结局:一项对比观察性研究。
Indian J Ophthalmol. 2021 Nov;69(11):3289-3295. doi: 10.4103/ijo.IJO_1293_21.
3
Development and Progression of Diabetic Retinopathy in Adolescents and Young Adults With Type 2 Diabetes: Results From the TODAY Study.2型糖尿病青少年和青年患者糖尿病视网膜病变的发生与进展:今日研究结果
Diabetes Care. 2021 Sep 16;45(5):1049-55. doi: 10.2337/dc21-1072.
4
Incidence of Proliferative Diabetic Retinopathy and Other Neovascular Sequelae at 5 Years Following Diagnosis of Type 2 Diabetes.2 型糖尿病诊断 5 年后增殖性糖尿病视网膜病变及其他新生血管并发症的发生率。
Diabetes Care. 2021 Nov;44(11):2518-2526. doi: 10.2337/dc21-0228. Epub 2021 Sep 2.
5
Next-generation anti-VEGF agents for diabetic macular oedema.用于糖尿病黄斑水肿的新一代抗 VEGF 药物。
Eye (Lond). 2022 Feb;36(2):273-277. doi: 10.1038/s41433-021-01722-8. Epub 2021 Aug 9.
6
Trends in Prevalence of Diabetes and Control of Risk Factors in Diabetes Among US Adults, 1999-2018.1999 - 2018年美国成年人糖尿病患病率及糖尿病危险因素控制趋势
JAMA. 2021 Jun 25;326(8):1-13. doi: 10.1001/jama.2021.9883.
7
Postintervention Effects of Varying Treatment Arms on Glycemic Failure and β-Cell Function in the TODAY Trial.TODAY 试验中不同治疗组对血糖失败和β细胞功能的干预后影响。
Diabetes Care. 2021 Jan;44(1):75-80. doi: 10.2337/dc20-0622. Epub 2020 Nov 10.
8
Outer retinal hyperreflective deposits (ORYD): a new OCT feature in naïve diabetic macular oedema after PPV with ILM peeling.外网状层高反射性沉积物(ORYD):PPV 联合 ILM 剥离术后未经治疗的糖尿病黄斑水肿的一种新 OCT 特征。
Br J Ophthalmol. 2020 May;104(5):666-671. doi: 10.1136/bjophthalmol-2019-314523. Epub 2019 Aug 7.
9
Diabetic macular edema: Evidence-based management.糖尿病性黄斑水肿:循证管理。
Indian J Ophthalmol. 2018 Dec;66(12):1736-1750. doi: 10.4103/ijo.IJO_1240_18.
10
Diabetic retinopathy in type 1 diabetes patients in Western Norway.挪威西部 1 型糖尿病患者的糖尿病视网膜病变。
Acta Ophthalmol. 2018 Aug;96(5):465-474. doi: 10.1111/aos.13654. Epub 2018 Jan 25.